1 |
Vakil N, van Zanten SV, Kahrilas P, et al. The Montreal definition and classification of gastroesophageal reflux disease: a global evidence-based consensus [J]. Am J Gastroenterol, 2006, 101(8): 1900-1920; quiz 1943.
|
2 |
中华医学会病理学分会消化疾病学组筹备组.胃食管反流病、Barrett食管和食管胃交界腺癌病理诊断共识[J].中华病理学杂志, 2017, 46(2): 79-83.
|
3 |
Frazzoni M, Manta R, Mirante VG, et al. Esophageal chemical clearance is impaired in gastro-esophageal reflux disease--a 24-h impedance-pH monitoring assessment [J]. Neurogastroenterol Motil, 2013, 25(5): 399-406, e295.
|
4 |
Patel A, Sayuk GS, Gyawali CP. Parameters on esophageal pH- impedance monitoring that predict outcomes of patients with gastroesophageal reflux disease [J]. Clin Gastroenterol Hepatol, 2015, 13(5): 884-891.
|
5 |
Roman S, Gyawali CP, Savarino E, et al. Ambulatory reflux monitoring for diagnosis of gastro-esophageal reflux disease: Update of the Porto consensus and recommendations from an international consensus group [J]. Neurogastroenterol Motil, 2017, 29(10): 1-15.
|
6 |
Zerbib F, Roman S, Ropert A, et al. Esophageal pH-Impedance monitoring and symptom analysis in GERD: A study in patients off and on therapy [J]. Am J Gastroenterol, 2006, 101(9): 1956-1963.
|
7 |
Savarino E, Marabotto E, Zentilin P, et al. The added value of impedance-pH monitoring to rome III criteria in distinguishing functional heartburn from non-erosive reflux disease [J]. Dig Liver Dis, 2011, 43(7): 542-547.
|
8 |
Shafik A, El-Sibai O, Shafik AA, et al. Effect of topical esophageal acidification on salivary secretion: identification of the mechanism of action [J]. J Gastroenterol Hepatol, 200, 20(12): 1935-1939.
|
9 |
Martinucci I, De BN, Savarino E, et al. Esophageal baseline impedance levels in patients with pathophysiological characteristics of functional heartburn [J]. Neurogastroenterol Motil, 2014, 26(4): 546-555.
|
10 |
Frazzoni M, Savarino E, Bortoli ND, et al. Analyses of the post-reflux swallow-induced peristaltic wave index and nocturnal baseline impedance parameters increase the diagnostic yield of patients with reflux disease [J]. Clin Gastroenterol Hepatol, 2016, 14(1): 40-46.
|
11 |
Frazzoni M, Bertani H, Conigliaro R, et al. Neoplastic progression in short-segment Barrett's oesophagus is associated with impairment of chemical clearance, but not inadequate acid suppression by proton pump inhibitor therapy [J]. Aliment Pharmacol Ther, 2014, 40(7): 835-842.
|
12 |
Frazzoni M, De BN, Frazzoni L, et al. The added diagnostic value of postreflux swallow-induced peristaltic wave index and nocturnal baseline impedance in refractory reflux disease studied with on-therapy impedance-pH monitoring [J]. Neurogastroenterol Motil, 2017. 29(3). doi: 10.1111/nmo.12947. Epub 2016 Sep 12.
|
13 |
Kandulski A, Weigt J, Caro C, et al. Esophageal intraluminal baseline impedance differentiates gastroesophageal reflux disease from functional heartburn [J]. Clin Gastroenterol Hepatol, 2015, 13(6): 1075-1081.
|
14 |
Kessing BF,Bredenoord AJ, Weijenborg PW, et al. Esophageal acid exposure decreases intraluminal baseline impedance levels [J]. Am J Gastroenterol, 2011, 106(12): 2093-2097.
|
15 |
Zhong C, Duan L, Wang K, et al. Esophageal intraluminal baseline impedance is associated with severity of acid reflux and epithelial structural abnormalities in patients with gastroesophageal reflux disease [J]. J Gastroenterol, 2013, 48(5): 601-610.
|
16 |
Patel A, Wang D, Sainani N, et al. Distal mean nocturnal baseline impedance on pH-impedance monitoring predicts reflux burden and symptomatic outcome in gastro-oesophageal reflux disease [J]. Aliment Pharmacol Ther, 2016, 44(8): 890-898.
|
17 |
Xie C, Sifrim D, Li Y, et al. Esophageal Baseline Impedance Reflects Mucosal Integrity and Predicts Symptomatic Outcome With Proton Pump Inhibitor Treatment [J]. J Neurogastroenterol Motil, 2018, 24(1): 43-50.
|
18 |
Rinsma NF, Farré R, Bouvy ND, et al. The effect of endoscopic fundoplication and proton pump inhibitors on baseline impedance and heartburn severity in GERD patients [J]. Neurogastroenterol Motil, 2015, 27(2): 220-228.
|
19 |
Ye BX, Jiang LQ, Lin L, et al. Reflux episodes and esophageal impedance levels in patients with typical and atypical symptoms of gastroesophageal reflux disease [J]. Medicine (Abingdon), 2017, 96(37): e7978.
|
20 |
Cho YK, Lee JS, Lee TH, et al. The Relationship of the Post-reflux Swallow-induced Peristaltic Wave Index and Esophageal Baseline Impedance with Gastroesophageal Reflux Disease Symptoms [J]. J Neurogastroenterol Motil, 2017, 23(2): 237-244.
|
21 |
陈旻湖,侯晓华,肖英莲,等. 2014年中国胃食管反流病专家共识意见[J].胃肠病学,2015, (3): 155-168.
|
22 |
中国胃食管反流病共识意见专家组.中国胃食管反流病共识意见(2006·10三亚) [J].中华内科杂志, 2007, 46(2): 170-173.
|
23 |
Gao F, Gao Y, Chen X, et al. Comparison of esophageal function tests in chinese patients with functional heartburn and reflux hypersensitivity [J]. Gastroenterol Res Pract, 2017, 2017(6): 3596148.
|
24 |
Aziz Q, Fass R, Gyawali CP, et al. Functional esophageal disorders [J]. Gastroenterology, 2016, 130(5): 1459-1465.
|
25 |
Yamasaki T, Fass R. Reflux hypersensitivity: A new functional esophageal disorder [J]. J Neurogastroenterol Motil, 2017, 23(4): 495-503.
|
26 |
Tack J, Drossman DA. What's new in Rome IV? [J]. Neurogastroenterol Motil, 2017, 29(9). doi: 10.1111/nmo.13053. Epub 2017 Mar 17.
|
27 |
Frazzoni L, Frazzoni M, De BN, et al. Critical appraisal of Rome IV criteria: hypersensitive esophagus does belong to gastroesophageal reflux disease spectrum [J]. Ann Gastroenterol, 2018, 31(1): 1-7.
|
28 |
Schmulson MJ, Drossman DA. What is new in Rome IV [J]. J Neurogastroenterol Motil, 2017, 23(2): 151-163.
|
29 |
Frazzoni M, Conigliaro R, Melotti G. Weakly acidic refluxes have a major role in the pathogenesis of proton pump inhibitor-resistant reflux oesophagitis [J]. Aliment Pharmacol Ther, 2011, 33(5): 601-606.
|
30 |
Kohata Y, Fujiwara Y, Yamagami H, et al. Usefulness of baseline impedance in patients with proton pump inhibitor-refractory nonerosive reflux disease [J]. J Gastroenterol Hepatol, 2015. 30(S1): 36-40.
|
31 |
Jiang L, Ye B, Lin L, et al. Role of altered esophageal intraluminal baseline impedance levels in patients with gatroesophageal reflux disease refractory to proton pump inhibitors [J]. Medicine (Abingdon), 2016, 95(33): e4351.
|
32 |
Ribolsi M, Savarino E, Bortoli ND, et al. Reflux pattern and role of impedance-pH variables in predicting PPI response in patients with suspected GERD-related chronic cough [J]. Aliment Pharmacol Ther, 2014, 40(8): 966-973.
|
33 |
Zentilin P, Savarino V, Marabotto E, et al. Esophageal baseline impedance levels allow the identification of esophageal involvement in patients with systemic sclerosis [J]. Semin Arthritis Rheum, 2017, 47(4): 569.
|
34 |
Tenca A, Bortoli ND, Mauro A, et al. Esophageal chemical clearance and baseline impedance values in patients with chronic autoimmune atrophic gastritis and gastro-esophageal reflux disease [J]. Dig Liver Dis, 2017, 49(9): 978-983
|
35 |
Fukahori S, Yagi M, Ishii S, et al. A baseline impedance analysis in neurologically impaired children: A potent parameter for estimating the condition of the esophageal mucosa [J]. Neurogastroenterol Motil, 2017, 29(6). doi: 10.1111/nmo.13012. Epub 2017 Jan 13.
|
36 |
Matsumura T, Arai M, Ishigami H, et al. Evaluation of esophageal mucosal integrity in patients with gastroesophageal reflux disease [J]. Digestion, 2018, 97(1): 31-37.
|